Meissner Acquires PDC Aseptic Filling Systems
Meissner Filtration Products has acquired PDC Aseptic Filling Systems, a supplier of aseptic filling systems and sealers, to expand Meissner's automated platform offerings.
On Jan. 12, 2018, Meissner Filtration Products, a developer, manufacturer, and supplier of microfiltration and single-use systems, announced that it has acquired PDC Aseptic Filling Systems, a supplier of aseptic filling systems and sealers.
“PDC’s technology is a natural extension of our current portfolio and fits with our trajectory as pertains to providing automated platforms that enable robust pharmaceutical processing operations,” stated Chris Meissner, CEO of Meissner, in a company press release. “We are committed to providing our clients with process solutions that reduce risk, while at the same time enhance productivity, and this makes PDC a great fit for our organization.”
PDC’s products will add to Meissner’s current process solutions, which include filtration, single-use systems, fluid handling, and unit processing offerings. The filling systems enable automated aseptic filing of pharmaceutical process liquids, while the sealing equipment reduces cycle times associated with aseptic disconnections, according to the company.
Source: Meissner
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
